Literature DB >> 30943746

Acanthopanax senticosus polysaccharide suppressing proliferation and metastasis of the human non-small cell lung cancer NCI-H520 cells is associated with Wnt/β-catenin signaling.

D Sun1, J Chen2, H Hu3, S Lin3, L Jin1, L Luo4, X Yan3, C Zhang5.   

Abstract

Lung cancer (LC) is the highest lethality in all tumors. Non-small cell lung cancer (NSCLC) accounts for about 80% of all LC. Acanthopanax senticosus polysaccharide (ASPS) is extracted from the root of Acanthopanax senticosus (AS). Herein, we examined the effect and molecular mechanism of ASPS on NSCLC. The proliferation, invasion and migration of NCI-H520 cells were detected by cell counting kit-8 (CCK-8), transwell assay and wound healing assay, respectively. The epithelial-mesenchymal transition (EMT) and Wnt/β-catenin pathway-related factors were evaluated using quantitative real-time PCR (QRT-PCR) and western blot assay. Our results observed that ASPS significantly decreased the proliferation of cells at 24 and 48 h. Moreover, ASPS markedly repressed the invasion and migration capacities of cells in a concentration-dependent manner. Besides, ASPS obviously down-regulated the levels of matrix metalloproteinase-2 (MMP-2), MMP-9, fibronectin 1 (FN1), vimentin, wnt3a, phosphorylated-glycogen synthase kinase 3β (p-GSK3β) and cyclin D1, whereas, up-regulating E-cadherin level. The level of GSK3β was not changed in the different groups. ASPS conspicuously inhibited the abilities of proliferation and metastasis in human non-small cell lung cancer cell line NCI-H520 possibly by suppressing Wnt/β-catenin pathway mediated-EMT.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30943746     DOI: 10.4149/neo_2018_180913N689

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  2 in total

1.  Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.

Authors:  Zhenjie Zhuang; Tong Lin; Zhanhua Liu; Lizhu Lin; Lixia Luo; Weixin Zhou; Junmao Wen; Haifu Huang
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

2.  Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer.

Authors:  Na Xiao; Hailang He; Jing Wang; Li Zhang; Brandon Chow; Fanchao Feng; Yong Xu; Jingyi Huang; Xianmei Zhou; Rui Dong
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.